Spotlight on Tdap5 Vaccine (Covaxis®) as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and Pertussis: In Children (Aged ≥4 Years) …

LJ Scott - Pediatric Drugs, 2011 - Springer
Covaxis®(also licensed as Triaxis® or Adacel® in individual countries) is a Tdap 5 (ie
combined tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis …
被引用次数：6 相关文章

Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged≥ 4 years) …

LJ Scott - Paediatric drugs, 2011 - pubmed.ncbi.nlm.nih.gov
Covaxis®(also licensed as Triaxis® or Adacel® in individual countries) is a Tdap₅ (ie
combined tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis …

Spotlight on [Tdap. sub. 5] vaccine (Covaxis [R]) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged [greater …

LJ Scott - Pediatric Drugs, 2011 - go.gale.com
Covaxis [R](also licensed as Triaxis [R] or Adacel [R] in individual countries) is a [Tdap. sup.
5](ie combined tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis …

Spotlight on Tdap₅ vaccine (Covaxis®) as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis: in children (aged≥ 4 years) …

LJ Scott - Paediatric Drugs, 2011 - europepmc.org
Covaxis®(also licensed as Triaxis® or Adacel® in individual countries) is a Tdap₅ (ie
combined tetanus toxoid, reduced diphtheria toxoid, five component acellular pertussis …